Alligator Bioscience
Sweden - LundBiotechnology
Focus: Alligator Bioscience is a Swedish antibody therapeutics company founded in 2001, focused exclusively on oncology programs with a pipeline of early-stage immuno-oncology assets. The company is publicly listed and operates as a focused biotech player in the competitive antibody space.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Alligator Bioscience
AI assessmentNot HiringNo open roles listed right now. Follow Alligator Bioscience to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ADC-1013
NeoplasmsClinical Trials (1)
NCT02379741ADC-1013 First-in-Human Study
Phase 1Help build intelligence for Alligator Bioscience
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.